Tested Applications
| Positive WB detected in | SH-SY5Y cells, HeLa cells, PC-3 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
11928-1-AP targets TMEFF2 in WB, IHC, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag2609 Product name: Recombinant human TMEFF2 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-374 aa of BC008973 Sequence: MVLWESPRQCSSWTLCEGFCWLLLLPVMLLIVARPVKLAAFPTSLSDCQTPTGWNCSGYDDRENDLFLCDTNTCKFDGECLRIGDTVTCVCQFKCNNDYVPVCGSNGESYQNECYLRQAACKQQSEILVVSEGSCATDAGSGSGDGVHEGSGETSQKETSTCDICQFGAECDEDAEDVWCVCNIDCSQTNFNPLCASDGKSYDNACQIKEASCQKQEKIEVMSLGRCQDNTTTTTKSEDGHYARTDYAENANKLEESAREHHIPCPEHYNGFCMHGKCEHSINMQEPSCRCDAGYTGQHCEKKDYSVLYVVPGPVRFQYVLIAAVIGTIQIAVICVVVLCITRKCPRSNRIHRQKQNTGHYSSDNTTRASTRLI Predict reactive species |
| Full Name | transmembrane protein with EGF-like and two follistatin-like domains 2 |
| Calculated Molecular Weight | 374 aa, 41 kDa |
| Observed Molecular Weight | 41 kDa |
| GenBank Accession Number | BC008973 |
| Gene Symbol | TMEFF2 |
| Gene ID (NCBI) | 23671 |
| RRID | AB_2204477 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9UIK5 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
TMEFF2 (Transmembrane protein with EGF-like and two follistatin-like domains 2, also known as TPEF or HPP1) is a type I transmembrane glycoprotein belonging to the TMEFF family, containing an epidermal growth factor (EGF)-like domain and two follistatin-like domains in its extracellular region. This protein is primarily expressed in the brain and certain tumor tissues, exhibiting dual functions: in the nervous system, it participates in regulating the proliferation and differentiation of neural precursor cells; in cancer, it often acts as a tumor suppressor by inhibiting tumor cell proliferation, inducing apoptosis, and modulating signaling pathways such as TGF-β. Promoter methylation of TMEFF2 is closely associated with the occurrence and progression of various cancers.
Protocols
| Product Specific Protocols | |
|---|---|
| WB protocol for TMEFF2 antibody 11928-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
TMEFF2 Polyclonal Antibody (11928-1-AP) has 2 total citations. The citing journals are Cancer Cell International and The Journal of Immunology. The associated research fields include glioma prognosis (examined via TMEFF2 promoter hypermethylation as an unfavorable prognostic marker using IHC) and multiple myeloma (identified through gene expression profiling of potential cancer-testis antigens using WB). Applications used were IHC and WB on human samples.
| Species | Application | Title |
|---|---|---|
Cancer Cell Int TMEFF2 promoter hypermethylation is an unfavorable prognostic marker in gliomas. | ||
J Immunol Gene expression profiling and real-time PCR analyses identify novel potential cancer-testis antigens in multiple myeloma. |





